3 Articles on RYONCIL GvHD Trial Results Published in BBMT
(WorldNews Business)

CLINICAL OUTCOMES USING RYONCIL™ (REMESTEMCEL-L) IN CHILDREN AND ADULTS WITH SEVERE INFLAMMATORY GRAFT VERSUS HOST DISEASE PUBLISHED IN THREE ARTICLES IN BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Key points: Biology of Blood and Marrow Transplantation, the official publication of the American Society for Transplantation and Cellular Therapy, publishes three peer-reviewed articles detailing results from three separate trials of remestemcel-L in children and adults with acute graft versus host disease Publications highlight consistent benefits seen across all three trials in patients with greatest levels of inflammation and the most severe grades of the disease Trial results underpin...